Vertex Sues Lupin to Block Copies of Cystic Fibrosis Drug

Vertex said Lupin’s proposed generic version of Kalydeco, its treatment for cystic fibrosis, infringes a patent for the drug.

• Vertex is seeking court order blocking copies until patent has expired and cash compensation if copies are made before then, according to complaint filed Tuesday in federal court in Wilmington, Delaware
• Patent was issued in May 2020, complaint says, and expires in August 2029, according to FDA’s Orange Book
• Vertex in July 2020 sued Sun Pharmaceutical over the same patent; that case, also in Delaware, has a three-day bench trial set for October 2022
• NOTE: Continued Innovation Delays Generics ...